CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
Jun. 30, 2023	Jun. 30, 2022
OPERATING ACTIVITIES:
Net loss	$ (10,378)	$ (15,014)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation	13,161	13,618
Amortization, including accretion and write-off of deferred financing costs	4,004	4,323
Deferred income taxes	(3,782)	(1,868)
Loss of equity method investee	500	458
Gain on sale of fixed assets	(854)	(95)
Share-based compensation expense	1,271	2,834
Excess tax deficiency related to share-based compensation expense	66	259
Gain on settlement of net investment hedge	0	(3,716)
Changes in operating assets and liabilities:
Accounts receivable, net	(28,100)	(15,481)
Inventories, net	(23,142)	(11,864)
Prepaid expenses and other assets	3,313	(15,538)
Accounts payable	27,069	16,577
Accrued expenses and other liabilities	12,184	7,689
Net cash used for operating activities	(4,688)	(17,818)
INVESTING ACTIVITIES:
Capital expenditures, including intangibles	(18,025)	(14,890)
Proceeds from sale of fixed assets	1,729	140
Proceeds from settlement of net investment hedge	0	3,820
Investment in venture capital fund, net	0	(450)
Net cash used for investing activities	(16,296)	(11,380)
FINANCING ACTIVITIES:
Revolving credit facility borrowings	42,000	11,190
Revolving credit facility payments	(38,068)	(16,500)
Proceeds from issuance of debt	16,402	19,163
Repayments of debt	(18,086)	(20,358)
Earn-out consideration cash payment	0	(6,276)
Repurchase of Common Shares to satisfy employee tax withholding	(1,325)	(699)
Net cash provided by (used for) financing activities	923	(13,480)
Effect of exchange rate changes on cash and cash equivalents	(32)	(2,177)
Net change in cash and cash equivalents	(20,093)	(44,855)
Cash and cash equivalents at beginning of period	54,798	85,547
Cash and cash equivalents at end of period	34,705	40,692
Supplemental disclosure of cash flow information:
Cash paid for interest, net	5,622	3,022
Cash paid for income taxes, net	$ 5,927	$ 3,936

The aggregate expense charged against earnings to allocate the cost of intangible assets including deferred financing costs (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Also included in this amount is the accretion of the debt discount and the deferred financing costs which are a component of interest expense representing the periodic charge against earnings to reflect amortization of debt discounts and deferred financing costs over the life of the related debt instrument. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.